Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

59.50
+1.382.37%
Post-market: 59.550.0500+0.08%19:59 EDT
Volume:2.45M
Turnover:149.15M
Market Cap:5.75B
PE:-12.50
High:62.54
Open:59.72
Low:58.89
Close:58.12
52wk High:78.48
52wk Low:44.12
Shares:96.69M
Float Shares:93.17M
Volume Ratio:1.25
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7595
EPS(LYR):-6.4700
ROE:-26.09%
ROA:-14.20%
PB:3.29
PE(LYR):-9.20

Loading ...

USPTO Ruling Impacts Editas Medicine CRISPR IP Position

TIPRANKS
·
Mar 27

CRISPR Therapeutics Ag : Leerink Partners Cuts Target Price to $60 From $74

THOMSON REUTERS
·
Mar 25

Is CRISPR Therapeutics (CRSP) Attractive After Recent Share Price Weakness And DCF Upside?

Simply Wall St.
·
Mar 22

Crispr Therapeutics Completes $600 Million Convertible Notes Offering

TIPRANKS
·
Mar 17

CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story

Simply Wall St.
·
Mar 14

Press Release: Morningstar, Inc. Declares Quarterly Dividend of 50 Cents Per Share

Dow Jones
·
Mar 14

Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS

TIPRANKS
·
Mar 13

CRSP, SOLQ: Cathie Wood’s ARK ‘Buys the Dip’ in CRISPR and Solana Staking ETF

TIPRANKS
·
Mar 11

Crispr Therapeutics prices upsized convertible senior notes offering

TIPRANKS
·
Mar 11

Cathie Wood’s ARK Investment buys 281K shares of Crispr Therapeutics today

TIPRANKS
·
Mar 11

What's Going On With CRISPR Therapeutics Stock Today?

Benzinga_recent_news
·
Mar 11

Crispr Therapeutics falls -9.2%

TIPRANKS
·
Mar 11

Crispr Therapeutics Falls on $350M Senior Note Private Placement

Dow Jones
·
Mar 10

CRISPR Therapeutics plans USD 350 million convertible senior notes offering due 2031

Reuters
·
Mar 10

CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering

GlobeNewswire
·
Mar 10

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

Benzinga
·
Mar 10

Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Expectations and Forecast Revisions Draw Investor Focus

Simply Wall St.
·
Mar 05

CRISPR Therapeutics Takeover Chatter With Vertex Puts Investor Tradeoffs In Focus

Simply Wall St.
·
Mar 01

Crispr Therapeutics AG Surges on Takeover Buzz and Hype

TIPRANKS
·
Feb 28

Intellia Therapeutics Eyes 2026 Pivotal CRISPR Milestone

TIPRANKS
·
Feb 28